Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sul-121 (hydrochloride)

Sul-121 hydrochloride is a novel compound with anti-oxidative capacity that effectively inhibits airway inflammation and hyperresponsiveness (AHR) in experimental models of chronic obstructive pulmonary disease (COPD) . Sul-121 hydrochloride prevents lipopolysaccharide-induced airway neutrophilia and AHR in a dose-dependent manner. Sul-121 hydrochloride also demonstrates the ability to reduce oxidative stress markers in human airway smooth muscle cells. Sul-121 hydrochloride inhibits nuclear translocation of the NF-κB subunit, p65, thereby diminishing pro-inflammatory cytokine release.

Product Specifications

CAS Number

[1541170-25-5]

UNSPSC

12352005

Target

NF-κB

Type

Reference compound

Related Pathways

NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sul-121-hydrochloride.html

Smiles

O=C(C1(C)OC2=C(CC1)C(C)=C(O)C(C)=C2C)N3CCNCC3.Cl

Molecular Formula

C18H27ClN2O3

Molecular Weight

354.87

References & Citations

[1]The novel compound Sul-121 inhibits airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human SSC5D knockout cell line
ABC-KH14697 1 Vial

Human SSC5D knockout cell line

Ask
View Details
SLC37A2 antibody
FNab07957 100 µg

SLC37A2 antibody

Ask
View Details
LZTR1 Recombinant Protein Antigen
NBP2-49649PEP 0.1 mL

LZTR1 Recombinant Protein Antigen

Ask
View Details
Rabbit Polyclonal TIGD4 Antibody
NBP1-86303 0.1 mL

Rabbit Polyclonal TIGD4 Antibody

Ask
View Details
Human ISLR2 (NM_020851) AAV Particle
RC217963A1V 250 µL

Human ISLR2 (NM_020851) AAV Particle

Ask
View Details